These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 34313839)
1. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery. Zhu T; Yang Q; Shao J; Chen Z; Cai B; Mao G Virchows Arch; 2021 Nov; 479(5):905-917. PubMed ID: 34313839 [TBL] [Abstract][Full Text] [Related]
2. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma. Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359 [TBL] [Abstract][Full Text] [Related]
3. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells. Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489 [TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324 [TBL] [Abstract][Full Text] [Related]
5. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
6. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis. Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530 [TBL] [Abstract][Full Text] [Related]
7. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma. Zhao X; Tang YP; Wang CY; Wu JX; Ye F Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089 [TBL] [Abstract][Full Text] [Related]
8. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma. Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma. Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154 [TBL] [Abstract][Full Text] [Related]
10. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma. Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781 [TBL] [Abstract][Full Text] [Related]
12. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
13. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042 [TBL] [Abstract][Full Text] [Related]
14. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway. Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716 [TBL] [Abstract][Full Text] [Related]
15. SASS6 promotes proliferation of esophageal squamous carcinoma cells by inhibiting the p53 signaling pathway. Xu Y; Zhu K; Chen J; Lin L; Huang Z; Zhang J; Chen Y Carcinogenesis; 2021 Feb; 42(2):254-262. PubMed ID: 32671379 [TBL] [Abstract][Full Text] [Related]
16. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma. Liu M; Hu Y; Zhang MF; Luo KJ; Xie XY; Wen J; Fu JH; Yang H Cancer Lett; 2016 Jul; 377(1):97-104. PubMed ID: 27130665 [TBL] [Abstract][Full Text] [Related]
17. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma]. Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998 [TBL] [Abstract][Full Text] [Related]
18. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma. Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525 [TBL] [Abstract][Full Text] [Related]
19. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma. Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019 [TBL] [Abstract][Full Text] [Related]
20. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]